The SNHG3/miR-148a-3p axis-mediated high expression of DNMT1 is correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
Journal of Gastrointestinal Oncology · 2025-10 · 16 (5) · 2357-2376
DOI: 10.21037/jgo-2025-641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal Oncology, 2025-10. Verfasst von Ninghua Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Affiliated Hospital of Nantong University, Nantong, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Epigenetic reprogramming, particularly DNA methylation mediated by DNA-methyltransferase 1 (DNMT1), plays a crucial role in the pathogenesis of hepatocellular carcinoma (HCC). However, the regulatory mechanisms underlying DNMT1 overexpression and its relationship with immune infiltration in HCC remain unclear. This study aimed to investigate the expression pattern, prognostic significance, and regulatory network of DNMT1 in HCC, as well as its correlation with the tumor immune microenvironment.
Methods
A pan-cancer analysis of DNMT1 expression and prognosis was conducted using The Cancer Genome Atlas (TCGA) data. A cohort of 102 pairs of HCC and adjacent normal tissues from patients who underwent surgical resection was analyzed by immunohistochemistry (IHC). Upstream regulatory non-coding RNAs (ncRNAs) were identified by bioinformatics analyses, including an expression correlation analysis, survival analysis, and competing endogenous RNA (ceRNA) network construction. The relationship between DNMT1 expression and immune cell infiltration was evaluated using multiple algorithms, including TIMER, CIBERSORT, and xCell. A Gene Set Enrichment Analysis (GSEA) was performed to identify the DNMT1-associated functional pathways.
Results
DNMT1 was significantly overexpressed in the HCC tissues compared to the normal control tissues, and was correlated with poor overall survival (OS) and relapse-free survival (RFS). High DNMT1 expression was associated with advanced histological grade, elevated alpha-fetoprotein (AFP) levels, and older age (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy, Affiliated Hospital of Nantong University, Nantong, China.
- Department of Cancer Center, Affiliated Hospital of Nantong University, Nantong, China.
- Department of Radiation Oncology, Nantong University, Nantong, China.
- Department of Oncology, Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai, Shanghai, China.
- Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, China.
ORCID-Profile: Ninghua Yao
Zitieren
APA
Yao, N., Qu, G., Shi, Y., Miao, H., Sun, G., Sun, J., Zheng, W., & Zhao, H. (2025). The SNHG3/miR-148a-3p axis-mediated high expression of DNMT1 is correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. Journal of Gastrointestinal Oncology, 16(5), 2357-2376. https://doi.org/10.21037/jgo-2025-641
Vancouver
Yao N, Qu G, Shi Y, Miao H, Sun G, Sun J, et al. The SNHG3/miR-148a-3p axis-mediated high expression of DNMT1 is correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 2025;16(5):2357-2376. doi:10.21037/jgo-2025-641
BibTeX
@article{Yao2025,
author = {Yao, Ninghua and Qu, Ganling and Shi, Yumeng and Miao, Huajie and Sun, Gaojia and Sun, Jie and Zheng, Wenjie and Zhao, Hongyu},
title = {The SNHG3/miR-148a-3p axis-mediated high expression of DNMT1 is correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma},
journal = {Journal of Gastrointestinal Oncology},
year = {2025},
volume = {16},
number = {5},
pages = {2357--2376},
doi = {10.21037/jgo-2025-641}
}
EUVIMED